Targeted delivery of galunisertib using machine perfusion reduces fibrogenesis in an integrated ex vivo renal transplant and fibrogenesis model. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bph.16220
PubMed Identifier: 37596999
Publication URI: http://europepmc.org/abstract/MED/37596999
Type: Journal Article/Review
Volume: 181
Parent Publication: British journal of pharmacology
Issue: 3
ISSN: 0007-1188